This inventor holds 1 USPTO granted patent. Top assignee: Hybridon, Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations of Susan Meschwitz in Pathogen-Inhibitory Agents
Introduction
Susan Meschwitz is an accomplished inventor based in Saunderstown, Rhode Island. He has made significant contributions to the field of biotechnology, particularly in the development of novel antisense oligonucleotides. His work focuses on creating innovative solutions to combat pathogenic infections.
Latest Patents
Susan Meschwitz holds a patent for "Branched oligonucleotides as pathogen-inhibitory agents." This patent describes novel antisense oligonucleotides that exhibit increased resistance to nuclease attack, enhancing their efficacy in fighting pathogenic infections. The oligonucleotides consist of two or more identical or different sequences, each complementary to a nucleic acid sequence of a pathogen that is essential for the pathogen's metabolism and reproduction. The sequences can target the same or different nucleic acid sequences within a single pathogen, different strains of the same pathogen, or various pathogens. The preferred embodiment of these sequences is coupled via a 3′-3′ linkage, which significantly reduces 3′ nucleolytic degradation.
Career Highlights
Throughout his career, Susan Meschwitz has been associated with Hybridon, Inc., where he has contributed to groundbreaking research in the field of oligonucleotide therapeutics. His innovative approach has paved the way for advancements in medical treatments targeting infectious diseases.
Collaborations
One of his notable collaborators is Sudhir Agrawal, who has worked alongside him in the development of these pioneering technologies.
Conclusion
Susan Meschwitz's work in the field of pathogen-inhibitory agents showcases his dedication to advancing biotechnology. His innovative patents and collaborations highlight the importance of research in combating infectious diseases.